Woodstock Corp’s Emergent Biosolutions EBS Stock Holding History

Woodstock Corp’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,369	Closed	-$615K	–	163
2018 Q4	$615K	Hold	10,369	–	–	0.12%	107
2018 Q3	$683K	Hold	10,369	–	–	0.12%	109
2018 Q2	$524K	Hold	10,369	–	–	0.1%	116
2018 Q1	$546K	Hold	10,369	–	–	0.1%	113
2017 Q4	$482K	Sell	10,369 -2,643	-20%	-$111K	0.09%	118
2017 Q3	$526K	Sell	13,012 -9,917	-43%	-$359K	0.1%	115
2017 Q2	$778K	Hold	22,929	–	–	0.15%	99
2017 Q1	$666K	Sell	22,929 -4,602	-17%	-$140K	0.13%	104
2016 Q4	$904K	Sell	27,531 -5,606	-17%	-$168K	0.18%	93
2016 Q3	$1.04M	Buy	33,137 +11,120	+51%	+$323K	0.21%	89
2016 Q2	$619K	Buy	22,017 +1	+0%	+$39	0.13%	109
2016 Q1	$800K	Hold	22,016	–	–	0.17%	101
2015 Q4	$881K	Hold	22,016	–	–	0.19%	94
2015 Q3	$627K	Buy	+22,016	New	+$725K	0.14%	102

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodstock Corp's EBS Position: Q1 2019 in Review

Woodstock Corp sold out of Emergent Biosolutions (EBS) in Q1 2019, closing a stake of 10,369 shares — an estimated $615K sold.

Woodstock Corp first reported a position in EBS in Q3 2015 and held it in 14 quarters. The position peaked at $1.04M in Q3 2016. 272 funds tracked by Wall St. Rank hold EBS as of Q1 2019.

Woodstock Corp reported no remaining Emergent Biosolutions position as of Q1 2019 after selling out during the quarter.
Woodstock Corp sold 10,369 Emergent Biosolutions shares in Q1 2019, an estimated $615K.
Woodstock Corp first reported a position in Emergent Biosolutions in Q3 2015 and held it in 14 quarters.
Woodstock Corp's Emergent Biosolutions position peaked at $1.04M in Q3 2016.
272 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2019.

Based on Woodstock Corp's 13F filing for Q1 2019, filed 5 Apr 2019.